AUD 0.08
(-3.53%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -1.35 Million AUD | -146.7% |
2023 | 2.9 Million AUD | 24.96% |
2022 | 2.32 Million AUD | 141.82% |
2021 | 961.85 Thousand AUD | 2429.69% |
2020 | -41.28 Thousand AUD | -104.29% |
2019 | 962.25 Thousand AUD | 3151.38% |
2018 | -31.53 Thousand AUD | 0.0% |
2017 | - AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q4 | 1.21 Million AUD | 0.0% |
2024 Q2 | 1.58 Million AUD | 0.0% |
2024 FY | -198.66 Thousand AUD | -106.84% |
2023 Q4 | 278.71 Thousand AUD | 0.0% |
2023 Q2 | 2.62 Million AUD | 0.0% |
2023 FY | 2.9 Million AUD | 24.96% |
2022 Q2 | 2.37 Million AUD | 0.0% |
2022 FY | 2.32 Million AUD | 141.82% |
2022 Q4 | 5.39 Million AUD | 0.0% |
2021 Q2 | 1.02 Million AUD | 0.0% |
2021 FY | 961.85 Thousand AUD | 2429.69% |
2021 Q1 | - AUD | -100.0% |
2021 Q4 | -67.2 Thousand AUD | 0.0% |
2020 Q4 | 27.47 Thousand AUD | 0.0% |
2020 FY | -41.28 Thousand AUD | -104.29% |
2020 Q2 | -68.76 Thousand AUD | 0.0% |
2020 Q3 | - AUD | 100.0% |
2019 Q2 | 283.79 Thousand AUD | 0.0% |
2019 FY | 962.25 Thousand AUD | 3151.38% |
2019 Q4 | 706.36 Thousand AUD | 0.0% |
2019 Q3 | - AUD | -100.0% |
2018 Q2 | - AUD | 0.0% |
2018 Q3 | - AUD | 0.0% |
2018 Q4 | - AUD | 0.0% |
2018 FY | -31.53 Thousand AUD | 0.0% |
2017 FY | - AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Australian Clinical Labs Limited | 247.36 Million AUD | 100.549% |
BCAL Diagnostics Limited | 3.09 Million AUD | 143.813% |
Genetic Signatures Limited | -16.2 Million AUD | 91.622% |
Genetic Technologies Limited | 3.9 Million AUD | 134.765% |
Healius Limited | 541.2 Million AUD | 100.251% |
Imagion Biosystems Limited | -3.88 Million AUD | 65.044% |
Integral Diagnostics Limited | 103.8 Million AUD | 101.308% |
INOVIQ Ltd | -989.82 Thousand AUD | -37.133% |
Microba Life Sciences Limited | -8.58 Million AUD | 84.184% |
Monash IVF Group Limited | 85.5 Million AUD | 101.588% |
Sonic Healthcare Limited | 2.33 Billion AUD | 100.058% |